Daclatasvir

Daclatasvir stops HCV viral RNA replication and protein translation by directly inhibiting HCV protein NS5A.

Indications

It is used with another antiviral medication to treat chronic (long-lasting) hepatitis C

Dosage

Oral; 60mg for 12 weeks, dosage and duration may vary.

Special Precautions

Genotyping of virus is required before starting the medicine and used in combination only. Paediatric: Safety and efficacy not yet established Pregnancy: No human data available. Lactation: No human data available. Elderly: Use with caution.

Side Effects

Headache, fatigue, nausea, hemolytic anemia, diarrhea.

Drug Interactions

Amiodarone.